Amedisys, Inc. Forecast, price target & analysts
Amedisys, Inc. Target price 2025 - Analyst rating & recommendation
Amedisys, Inc. Classifications & Recommendation:
Amedisys, Inc. Price Target
| Target Price | $100.83 |
| Price | $97.16 |
| Potential |
3.78%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Amedisys, Inc. 2026 .
The average Amedisys, Inc. target price is $100.83.
This is
3.78%
register free of charge
$101.00
3.95%
register free of charge
$100.00
2.92%
register free of charge
|
|
| A rating was issued by 11 analysts: 1 Analysts recommend Amedisys, Inc. to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Amedisys, Inc. stock has an average upside potential 2026 of
3.78%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.35 | 2.45 |
| 5.01% | 4.24% | |
| EBITDA Margin | 9.69% | 10.62% |
| 2.80% | 9.59% | |
| Net Margin | 1.84% | 6.95% |
| 522.25% | 277.53% |
12 Analysts have issued a sales forecast Amedisys, Inc. 2025 . The average Amedisys, Inc. sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Amedisys, Inc. EBITDA forecast 2025. The average Amedisys, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Amedisys, Inc. Analysts have issued a net profit forecast 2025. The average Amedisys, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.31 | 5.18 |
| 536.67% | 295.42% | |
| P/E | 18.76 | |
| EV/Sales | 1.34 |
6 Analysts have issued a Amedisys, Inc. forecast for earnings per share. The average Amedisys, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current Amedisys, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
